Daly Chris D, Lim Kai Zheong, Lewis Jennifer, Saber Kelly, Molla Mohammed, Bar-Zeev Naor, Goldschlager Tony
Department of Surgery, Monash University, Clayton, VIC, Australia.
Department of Neurosurgery, Monash Medical Centre, Clayton, VIC, Australia.
BMC Musculoskelet Disord. 2017 Jul 20;18(1):312. doi: 10.1186/s12891-017-1681-3.
Lumbar microdiscectomy is the most commonly performed spinal surgery procedure, with over 300,000 cases performed annually in the United States alone. Traditionally, patients were advised to restrict post-operative activity as this was believed to reduce the risk of disc reherniation and progressive instability. However, this practice would often delay patients return to work. In contemporary practice many surgeons do not restrict patient post-operative activity due to the perception this practice is unnecessary. We describe a randomised controlled trial to assess the impact of activity restrictions on clinical outcome following lumbar discectomy.
METHODS/DESIGN: The lumbar microdiscectomy and post-operative activity restriction trial is a multi-centre, randomised, controlled single blinded trial. Two hundred ten patients due to undergo single level lumbar microdiscectomy without a history of previous spine surgery, infection or fracture are randomised to be advised either restricted or unrestricted activity for a period of 30 days following lumbar microdiscectomy. Actual adherence with trial allocation will be monitored bioelectronically via a wearable device. Outcome assessment at follow up will occur at 1, 3, 6 and 12 months. The primary outcome will be a composite endpoint comprising changes in Visual Analogue Scale (Leg and Back), Oswestry Disability Index and the absence of intervertebral disc reherniation or secondary intervention.
This randomised controlled trial will directly compare post-operative protocols of activity restrictions and no restrictions following lumbar discectomy with adherence monitored bioelectronically.
Australian New Zealand Clinical Trials Registry: ACTRN12616001360404 (retrospectively registered 30/09/2016).
腰椎显微椎间盘切除术是最常开展的脊柱外科手术,仅在美国每年就有超过30万例。传统上,建议患者限制术后活动,因为人们认为这可降低椎间盘再突出和渐进性不稳定的风险。然而,这种做法往往会延迟患者重返工作岗位。在当代实践中,许多外科医生不限制患者的术后活动,因为他们认为这种做法没有必要。我们描述了一项随机对照试验,以评估活动限制对腰椎间盘切除术后临床结局的影响。
方法/设计:腰椎显微椎间盘切除术与术后活动限制试验是一项多中心、随机、对照单盲试验。210例因单节段腰椎显微椎间盘切除术而就诊且无既往脊柱手术、感染或骨折史的患者被随机分为两组,一组在腰椎显微椎间盘切除术后30天被建议进行活动限制,另一组不限制活动。将通过可穿戴设备以生物电子方式监测对试验分配的实际依从性。随访时的结局评估将在1、3、6和12个月进行。主要结局将是一个综合终点,包括视觉模拟量表(腿部和背部)、Oswestry功能障碍指数的变化以及无椎间盘再突出或二次干预。
这项随机对照试验将直接比较腰椎间盘切除术后活动限制和不限制活动的术后方案,并以生物电子方式监测依从性。
澳大利亚新西兰临床试验注册中心:ACTRN1261600136(2016年9月30日追溯注册)。 404